Teriparatide Induced Delayed Persistent Hypercalcemia
Joint Authors
Randhawa, Jaskirat
Kistangari, Gaurav
Sadiek, Happy
Thiruchelvam, Nirosshan
Source
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-08-18
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Teriparatide, a recombinant PTH, is an anabolic treatment for osteoporosis that increases bone density.
Transient hypercalcemia is a reported side effect of teriparatide that is seen few hours following administration of teriparatide and resolves usually within 16 hours of drug administration.
Persistent hypercalcemia, although not observed in clinical trials, is rarely reported.
The current case describes a rare complication of teriparatide induced delayed persistent hypercalcemia.
American Psychological Association (APA)
Thiruchelvam, Nirosshan& Randhawa, Jaskirat& Sadiek, Happy& Kistangari, Gaurav. 2014. Teriparatide Induced Delayed Persistent Hypercalcemia. Case Reports in Endocrinology،Vol. 2014, no. 2014, pp.1-3.
https://search.emarefa.net/detail/BIM-499213
Modern Language Association (MLA)
Thiruchelvam, Nirosshan…[et al.]. Teriparatide Induced Delayed Persistent Hypercalcemia. Case Reports in Endocrinology No. 2014 (2014), pp.1-3.
https://search.emarefa.net/detail/BIM-499213
American Medical Association (AMA)
Thiruchelvam, Nirosshan& Randhawa, Jaskirat& Sadiek, Happy& Kistangari, Gaurav. Teriparatide Induced Delayed Persistent Hypercalcemia. Case Reports in Endocrinology. 2014. Vol. 2014, no. 2014, pp.1-3.
https://search.emarefa.net/detail/BIM-499213
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-499213
